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Abstract 
Injectable contraceptives are one of the most effective and convenient form of birth control 
means as more than 30 million women are using it throughout the world. There are two main 
choices of progestron only injectable methods include depot-medroxyprogesterone acetate 
(DMPA) used 90-day intervals and norethisterone enantate (NET-EN) used at 60-day 
intervals which only less than 1 million women use this type and it is used as Unidepo in 
Malaysia since 1976. It contains a synthetic hormonal progestron, like the natural female 
progesterone and its annual pregnancy rates is less than one per 100 users. Although birth 
control injections have a number of advantages, but like all other medications, have some 
potential side effects. One of the most worrying complications is bone density reduction. 
Bone loss and in turn osteoporosis as a systemic multi factorial skeletal disease is a growing 
public health concern especially in elderly people particularly in postmenopausal women that 
is reaching an epidemic proportion because the elderly population is the most rapidly 
growing segment of any population although it occurs in both sexes and all race/ethnicities 
and age groups. Several studies have reported lower bone mass in long-term injectable users, 
however, few studies have investigated the effect of hormonal contraceptives on BMD in 
premenopausal long-term users of injectables in their 40s, and there is very limited 
investigations related to the effect of NET-EN on BMD and no data on recovery of BMD on 
cessation of NET-EN use have been reported so far. The purpose of this study was to 
investigate the effect of duration of using Unidepo on Bone Mineral Density in 
postmenopausal women. This is a quasi-experimental study in menopause clinics in Kuala 
Lumpur where 133 postmenopausal women were interviewed for information on Injectable 
contraceptive use history and risk factors for decreased bone mineral density and ultrasound 
measurements of the left calcaneous were taken. Also, Height and weight were measured and 
BMI was calculated. All ethical aspects were considered.A two step hierarchical regression 
analysis was employed to examine effect of duration of Unidepo using on bone mineral 
density. Results revealed that use duration of Unidepo significantly was associated with BUA 
(broad band ultrasound attenuation) over and beyond of some socio demographic and 
reproductive factors, BMI, family history of osteoporosis, physical activity and calcium 
intake (ΔF (1, 109) = 18.69, p<0.001). This study suggest that bone density reduction in long 
term users is not completely reversible as when the duration of use increased the bone 
mineral density is decreased. 
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